3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate

C20H20F3N7O4 — CID 155487852

IUPAC3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate
SMILESCOc1cccc(OCCC[NH3+])c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1.O=C([O-])C(F)(F)F
InChIInChI=1S/C18H19N7O2.C2HF3O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17;3-2(4,5)1(6)7/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25);(H,6,7)
InChIKeyKTEQSHLWYUJSGV-UHFFFAOYSA-N
MW479.42 g/mol
LogP0.80
Rot. Bonds8

About 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate

3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate (PubChem CID 155487852) has the molecular formula C20H20F3N7O4 and a molecular weight of 479.42 g/mol. Its IUPAC name is 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate.

Molecular Properties

Compound Name3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate
PubChem CID155487852
Molecular FormulaC20H20F3N7O4
Molecular Weight479.42 g/mol
Exact Mass479.15
IUPAC Name3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate
SMILESCOc1cccc(OCCC[NH3+])c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1.O=C([O-])C(F)(F)F
InChIInChI=1S/C18H19N7O2.C2HF3O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17;3-2(4,5)1(6)7/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25);(H,6,7)
InChIKeyKTEQSHLWYUJSGV-UHFFFAOYSA-N
XLogP0.80
TPSA176.51 Ų
H-Bond Donors3
H-Bond Acceptors9
Rotatable Bonds8
Heavy Atoms34
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500479.42
LogP ≤ 50.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate?
The IUPAC name of 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate (CID 155487852) is 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate.
What is the SMILES notation for 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate?
The canonical SMILES for 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate is COc1cccc(OCCC[NH3+])c1-c1cc(Nc2cnc(C#N)cn2)n[nH]1.O=C([O-])C(F)(F)F.
What is the InChIKey of 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate?
The InChIKey is KTEQSHLWYUJSGV-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H19N7O2.C2HF3O2/c1-26-14-4-2-5-15(27-7-3-6-19)18(14)13-8-16(25-24-13)23-17-11-21-12(9-20)10-22-17;3-2(4,5)1(6)7/h2,4-5,8,10-11H,3,6-7,19H2,1H3,(H2,22,23,24,25);(H,6,7).
What are the key properties of 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate?
3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate has a molecular weight of 479.42 g/mol, XLogP of 0.80, 8 rotatable bonds, 3 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[3-[(5-cyanopyrazin-2-yl)amino]-1H-pyrazol-5-yl]-3-methoxyphenoxy]propylazanium;2,2,2-trifluoroacetate is sourced from PubChem (CID 155487852), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).